Advertisement

Topics

Cohen Esophageal Cancer Initiative Company Profile

21:03 EDT 21st September 2017 | BioPortfolio


News Articles [5312 Associated News Articles listed on BioPortfolio]

Esophageal Cancer Epidemiology Insights to 2025 [Report Updated: 10072017] Prices from USD $2950

DelveInsight Esophageal Cancer Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Esophageal Cancer in seven major markets US, France, Germany, Italy, Spain, UK and Jap...

In Esophageal Cancer, Women Have Stronger Responses

Chemoradiotherapy followed by surgery is standard of care for locally advanced esophageal cancer, but how the sexes respond to treatment is not uniform. Medscape Medical News

As One Type of Esophageal Cancer Declines, Another Rises Sharply

Even as the incidence of esophageal squamous cell carcinoma (ESCC) continues to decline in most countries, the incidence of esophageal adenocarcinoma (EAC) is rising to at least a comparable extent, a...

Scientists uncover a deadly ‘addiction’ in esophageal cancer

Scientists have discovered a new way of attacking esophageal cancer cells that could make use of an existing…

Esophageal Cancer Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10072017] Prices from USD $5750

DelveInsight's Esophageal Cancer Market Insights, Epidemiology and Market Forecast 2025 Reports provides an overview of the disease and global market size of the Esophageal Cancer for the 7MM United...

Esophageal Cancer Epidemiology Forecast To 2023 [Updated: 31052017] Prices from USD $2338

DelveInsight Esophageal Cancer Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Esophageal Cancer in seven major markets US, France, Germany, Italy, Spain, UK and Japa...

Results of NRG-RTOG 0436 highlight need for biomarkers in treatment of esophageal cancer

(NRG Oncology) NRG-RTOG 0436 has determined that adding an epidermal growth factor receptor (EGFR) inhibitor to a chemo-radiation regimen does not improve overall survival for patients with locally ad...

MIRO: Minimally Invasive Surgery for Esophageal Cancer

Patients with resectable esophageal cancer should undergo hybrid minimally invasive surgery, urge experts after a trial showed it markedly reduce postoperative morbidity vs open surgery. Medscape Me...

PubMed Articles [9602 Associated PubMed Articles listed on BioPortfolio]

Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer.

The neutrophil-to-lymphocyte ratio (NLR) has been reported to predict the prognosis of various malignant tumors, including esophageal cancer. However, no previous reports have supported the use of the...

The bidirectional association between oral cancer and esophageal cancer: A population-based study in Taiwan over a 28-year period.

Previous studies have revealed that patients with oral or esophageal cancer are at higher risk for subsequently developing a second primary malignancy. However, it remains to be determined what associ...

SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.

Esophageal cancer is a highly aggressive malignancy with very poor overall prognosis. Given the strong clinical relevance of SATB1 in esophagus cancer and other cancers suggested by previous studies, ...

Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer.

The objective of the study was to elucidate the impact of sarcopenia in elderly patients with esophageal cancer on postoperative complications and long-term survival after surgery for esophageal cance...

Non-coding RNAs: new biomarkers and therapeutic targets for esophageal cancer.

Esophageal cancer is one of the most common gastrointestinal malignant diseases and there is still no effective treatment. The incidence of esophageal cancer in the world is relatively high and on the...

Clinical Trials [7139 Associated Clinical Trials listed on BioPortfolio]

Self-Expandable Esophageal Radiation Stent:a Randomized Controlled Trial in Patients With Advanced Esophageal Cancer

To determine the response to treatment with a novel esophageal stent loaded with 125I seeds for intraluminal brachytherapy versus a conventional covered stent in patients with advanced eso...

Quality Initiative in Rectal Cancer (QIRC) Trial

The Quality initiative in rectal cancer (QIRC) trial will test if a strategy designed to positively influence surgeon practice can decrease hospital rates of permanent colostomy and local ...

Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer – Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)

A multicenter randomized comparison of primary esophagectomy against definitive chemoradiotherapy for the treatment of squamous esophageal cancer.

Photodynamic Therapy in Treating Patients With Early Esophageal Cancer

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. This may be an effective treatment for esophageal cancer. PURPOSE:...

Quality Of Life Outcomes Following Treatment for Esophageal Cancer

The goal of this study is to evaluate how treatment for esophageal cancer affects your quality of life. The findings of this study may help us understand how this disease and its treatment...

Companies [1651 Associated Companies listed on BioPortfolio]

Cohen Esophageal Cancer Initiative

The Claudia Cohen Research Foundation

The Claudia Cohen Research Foundation is dedicated exclusively to support research leading to the immunological treatment, control, and prevention of gynecologic cancer with a special emphasis on gyne...

Phillips & Cohen LLP

Phillips & Cohen LLP is the nation's most successful law firm representing whistleblowers. Qui tam lawsuits brought by Phillips & Cohen have resulted in civil and criminal recoveries totaling $5.3 bil...

Cohen Children’s Medical Center

Opened in 1983, the Steven and Alexandra Cohen Children’s Medical Center of New York is home to about 675 pediatricians, including 200 full-time physicians, and a total workf...

San Diego Plastic Surgeon

In 1990, Dr. Cohen was recruited to direct the Craniofacial Program at the University of Michigan in Ann Arbor. From 1993 to 1999, he was Co-Director of the Center for Craniofacial Disorders at Childr...

More Information about "Cohen Esophageal Cancer Initiative" on BioPortfolio

We have published hundreds of Cohen Esophageal Cancer Initiative news stories on BioPortfolio along with dozens of Cohen Esophageal Cancer Initiative Clinical Trials and PubMed Articles about Cohen Esophageal Cancer Initiative for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cohen Esophageal Cancer Initiative Companies in our database. You can also find out about relevant Cohen Esophageal Cancer Initiative Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record